Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer ; volume:15 ; number:1 ; day:10 ; month:5 ; year:2015 ; pages:1-11 ; date:12.2015
BMC cancer ; 15, Heft 1 (10.5.2015), 1-11, 12.2015
- Urheber
-
Pectasides, Dimitrios
- Beteiligte Personen und Organisationen
-
Karavasilis, Vasilios
Papaxoinis, George
Gourgioti, Georgia
Makatsoris, Thomas
Raptou, Georgia
Brettu, Elenē
Sgouros, Joseph
Samantas, Epaminontas
Basdanis, George
Papakostas, Pavlos
Bafaloukos, Dimitrios
Kotoula, Vassiliki
Kalofonos, Haralambos P.
Scopa, Chrisoula D.
Pentheroudakis, George
Fountzilas, George
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1406-7
- URN
-
urn:nbn:de:1111-2016110614333
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pectasides, Dimitrios
- Karavasilis, Vasilios
- Papaxoinis, George
- Gourgioti, Georgia
- Makatsoris, Thomas
- Raptou, Georgia
- Brettu, Elenē
- Sgouros, Joseph
- Samantas, Epaminontas
- Basdanis, George
- Papakostas, Pavlos
- Bafaloukos, Dimitrios
- Kotoula, Vassiliki
- Kalofonos, Haralambos P.
- Scopa, Chrisoula D.
- Pentheroudakis, George
- Fountzilas, George
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
Oxaliplatin-Associated Amaurosis Fugax
Oxaliplatin-induced lung fibrosis
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
Oxaliplatin-Associated Amaurosis Fugax
Oxaliplatin-induced lung fibrosis
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
Oxaliplatin-Associated Amaurosis Fugax
Oxaliplatin-induced lung fibrosis
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy